Vascular organoid patches offer new hope for coronary artery disease treatment
· Medical Xpressby International Society for Stem Cell Research
edited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western countries. IHD arises when blood vessels of the heart become clogged, blunting oxygen and nutrient supply to heart muscle cells, which eventually die off, leading to heart attack or heart failure. Although larger blood vessels can be replaced surgically to restore blood flow, there is currently no treatment targeting smaller blood vessels, so-called microvessels, which are essential for uniform blood circulation within the heart muscle.
Yasuhiro Shudo and his team from Stanford University have tested a method to regenerate microvessels in the heart with stem cell-derived vascular organoids. Their work was published in Stem Cell Reports.
Building and testing heart patches
Shudo's team began by making vascular organoids, which are small aggregates of cells capable of forming new blood vessels, from endothelial progenitor cells (EPCs) isolated from human blood and mesenchymal stem cell-derived smooth muscle cells (SMCs) from human bone marrow. The team then placed patches of vascular organoids onto the outer heart surface of pigs with IHD and followed them for four weeks.
Encouragingly, heart function in pigs receiving organoid patches improved compared with untreated animals, and progression of IHD toward heart failure was mitigated. The organoid patches survived for several weeks, and individual cells from the surface patches were found in deeper layers of the pig hearts, suggesting they are migrating into the heart.
Signs of vessel repair
The organoid patches also indirectly stimulated the pig hearts to make new microvessels and may have contributed to preserving heart muscle cell viability by releasing proteins that support cell survival. Collectively, these effects led to a measurably higher microvessel density and maturity in the transplanted hearts.
This proof-of-concept study shows that vascular organoids generated from an accessible source of human stem cells may be an effective treatment for IHD in a large animal model with heart size and physiology similar to the human heart. Future safety and efficacy studies will need to be performed before a similar treatment becomes available to patients with IHD.
Publication details
Topical Vascular Organoid Therapy Promotes Microvascular Regeneration and Functional Recovery in Porcine Ischemic Cardiomyopathy, Stem Cell Reports (2026). DOI: 10.1016/j.stemcr.2026.102999. www.cell.com/stem-cell-reports … 2213-6711(26)00210-9
Journal information: Stem Cell Reports
Key medical concepts
Clinical categories
Cardiology Provided by International Society for Stem Cell Research Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Vascular organoid patches offer new hope for coronary artery disease treatment (2026, July 2) retrieved 2 July 2026 from https://medicalxpress.com/news/2026-07-vascular-organoid-patches-coronary-artery.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.